Potential inhibiting activities of phytochemicals in Scilla natalensis bulbs against schistosomiasis
Article Sidebar
Main Article Content
Abstract
Schistosomiasis remains one of the severe ailments that affect both man and woman in South Africa. It is caused by blood fluke, and the rate at which it causes death is alarming in some areas of America, Asia as well as in African countries. It is a neglected tropical disease (NTD) with grave impact on social and economic situation of countries with low sanitation awareness. Thus, the search for lasting solution to this menace, has drawn the attention of many global researchers using phytochemicals from Scilla natalensis via in silico approach. The studied compounds were optimized using Spartan 14. Docking study was executed via Pymol, Autodock tool, Auto dock vina and discovery studio. Compound 9 with –8.2 kcal mol–1 and –9.4 kcal mol–1 as binding affinity proved to possess highest ability to inhibit glutathione S-transferase and thioredoxin-glutathione reductase than other compounds. Also, ADMET properties for compound 9 and praziquantel were explored and reported. Our findings may open the door for the design of novel drug-like molecules with better efficiency.
Metrics
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
The corresponding author transfers the copyright of the submitted manuscript and all its versions to Eclet. Quim., after having the consent of all authors, which ceases if the manuscript is rejected or withdrawn during the review process.
When a published manuscript in EQJ is also published in other journal, it will be immediately withdrawn from EQ and the authors informed of the Editor decision.
Self-archive to institutional, thematic repositories or personal webpage is permitted just after publication. The articles published by Eclet. Quim. are licensed under the Creative Commons Attribution 4.0 International License.
References
Adeoye, M. D.; Olarinoye, E. F.; Oyebamiji, A. K.; Latona, D. F. Theoretical evaluation of potential anti-alanine dehydrogenase activities of acetamide derivatives. Biointerface Res. Appl. Chem. 2022, 12 (6), 7469–7477. https://doi.org/10.33263/BRIAC126.74697477
Akachukwu, I.; Olubiyi, O. O.; Kosisochukwu, A.; John, M. C.; Justina, N. N. Structure-based study of natural products with anti-schistosoma activity. Curr. Comput. Aided Drug Des. 2017, 13 (2), 91–100. https://doi.org/10.2174/1573409913666170119114859
Allotey, P.; Reidpath, D. D.; Pokhrel, S. Social sciences research in neglected tropical diseases 1: The ongoing neglect in the neglected tropical diseases. Health Res. Policy Sys. 2010, 8, 32. https://doi.org/10.1186/1478-4505-8-32
Angelucci, F.; Sayed, A. A.; Williams, D. L.; Boumis, G.; Brunori, M.; Dimastrogiovanni, D.; Miele, A. E.; Pauly, F.; Bellelli, A. Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin. J. Biol. Chem. 2009, 284 (42), 28977–28985. https://doi.org/10.1074/jbc.M109.020701
Colley, D. G.; Bustinduy, A. L.; Secor, W. E.; King, C. H. Human schistosomiasis. Lancet. 2014, 383 (9936), 2253–2264. https://doi.org/10.1016/S0140-6736(13)61949-2
Cunningham, A. B. An investigation of the herbal medicinal trade in Natal/KwaZulu. Investigational Report 29; Institute of Natural Resources, 1988.
Engels, D.; Zhou, X.-N. Neglected tropical diseases: An effective global response to local poverty-related disease priorities. Infect. Dis. Poverty. 2020, 9, 10. https://doi.org/10.1186/s40249-020-0630-9
Eloff, J. N. A Sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med. 1998, 64 (8) 711–713. https://doi.org/10.1055/s-2006-957563
El-Seedi, H. R.; El-Shabasy, R.; Sakr, H.; Zayed, M.; El-Said, A. M. A.; Helmy, K. M. H.; Gaara, A. H. M.; Turki, Z.; Azeem, M.; Ahmed, A. M.; Boulos, L.; Borg-Karlson, A-K.; Göransson, U. Anti-schistosomiasis triterpene glycoside from the Egyptian medicinal plant Asparagus stipularis. Rev. Bras. Farmacogn. 2012, 22 (2), 314–318. https://doi.org/10.1590/S0102-695X2012005000004
Fadladdin, Y. A. J. Evaluation of antischistosomal activities of crude aqueous extracts of Artemisia annua, Nigella sativa, and Allium sativum against Schistosoma mansoni in hamsters. BioMed Res. Inter. 2022, 2022, 5172287. https://doi.org/10.1155/2022/5172287
Hutchings, A. A survey and analysis of traditional medicinal plants as used by the Zulu, Xhosa and Sotho. Bothalia. 1989, 19 (1), a947. https://doi.org/10.4102/abc.v19i1.947
Hutchings, A.; Haxton Scott, A. H.; Lewis, S. G.; Cunningham, A. Zulu medicinal plants: An inventory; University of Natal Press, 1996.
Kayuni, S.; Lampiao, F.; Makaula, P.; Juziwelo, L.; Lacourse, E. J.; Reinhard-Rupp, J.; Leutscher, P. D. C.; Stothard, J. R. A systematic review with epidemiological update of male genital schistosomiasis (MGS): A call for integrated case management across the health system in sub-Saharan Africa. Parasite Epidemiol Control. 2019, 4, e00077. https://doi.org/10.1016/j.parepi.2018.e00077
Klohe, K.; Koudou, B. G.; Fenwick, A.; Fleming, F.; Garba, A.; Gouvras, A.; Harding-Esch, E. M.; Knopp, S.; D’Souza, S.; Utzinger, J.; Vounatsou, P.; Waltz, J.; Zhang, Y.; Rollinson, D. A systematic literature review of schistosomiasis in urban and peri-urban settings. PLoS Negl. Trop. Dis. 2021, 15 (2), e0008995. https://doi.org/10.1371/journal.pntd.0008995
Latona, D. F.; Oyebamiji, A. K.; Mutiu, O. A., Olarinoye, E. F. Evaluation of some benzimidazole derivatives as hepatitis B&C protease inhibitors: Computational study. Trop. J. Nat. Prod. Res. 2022a, 6 (3), 416–421.
Latona, D. F.; Mutiu, O. A.; Adeoye, M. D.; Oyebamiji, A. K.; Akintelu, S. A.; Adedapo, A. S. In-silico investigation on chloroquine derivatives: A potential anti-COVID-19 main protease. Biointerface Res. Appl. Chem. 2022b, 12 (6), 8492–8501. https://doi.org/10.33263/BRIAC126.84928501
Lawal, H. A.; Uzairu, A.; Uba, S. QSAR, molecular docking studies, ligand-based design and pharmacokinetic analysis on Maternal Embryonic Leucine Zipper Kinase (MELK) inhibitors as potential anti-triple-negative breast cancer (MDA-MB-231cell line) drug compounds. Bull. Natl. Res. Centre. 2021, 45, 90. https://doi.org/10.1186/s42269-021-00541-x
Mander, M. The marketing of indigenous medicinal plants in South Africa: A case study in KwaZulu-Natal. Investigational Report 164; Institute of Natural Resources, 1997.
McTigue, M. A.; Williams, D. R.; Tainer, J. A. Crystal structures of a schistosomal drug and vaccine target: Glutathione S-transferase from Schistosoma japonica and its complex with the leading antischistosomal drug praziquantel. J. Mol. Biol. 1995, 246 (1), 21–27. https://doi.org/10.1006/jmbi.1994.0061
Molyneux, D. H. Combating the “other diseases” of MDG 6: Changing the paradigm to achieve equity and poverty reduction? Trans. R. Soc. Trop. Med. Hyg. 2008, 102 (6), 509–519. https://doi.org/10.1016/j.trstmh.2008.02.024
Molyneux, D. H.; Hotez, P. J.; Fenwick, A.; Newman, R. D.; Greenwood, B.; Sachs, J. Neglected tropical diseases and the Global Fund. Lancet. 2009, 373 (9660), 296–297. https://doi.org/10.1016/S0140-6736(09)60089-1
Mtemeli, F. L.; Shoko, R.; Ndlovu, J.; Mugumbate, G. In silico study of Cucurbita maxima compounds as potential therapeutics against schistosomiasis. Bioinform. Biol. Insights. 2022, 16, 1–10. https://doi.org/10.1177/11779322221100741
Olasupo, S. B.; Uzairu, A.; Shallangwa, G. A.; Uba, S. Unveiling novel inhibitors of dopamine transporter via in silico drug design, molecular docking, and bioavailability predictions as potential antischizophrenic agents. Futur. J. Pharm. Sci. 2021, 7, 63. https://doi.org/10.1186/s43094-021-00198-3
Oyeneyin, O. E.; Iwegbulam, C. G.; Ipinloju, N.; Olajide, B. F.; Oyebamiji, A. K. Prediction of the antiproliferative effects of some benzimidazolechalcone derivatives against MCF-7 breast cancer cell lines: QSAR and molecular docking studies. Org. Commun. 2022, 15 (3), 273–277. https://doi.org/10.25135/acg.oc.132.2203.2374
Porto, R.; Mengarda, A. C.; Cajas, R. A.; Salvadori, M. C.; Teixeira, F. S.; Arcanjo, D. D. R.; Siyadatpanah, A.; Pereira, M. L; Wilairatana, P.; Moraes, J. Antiparasitic properties of cardiovascular agents against human intravascular parasite Schistosoma mansoni. Pharmaceuticals. 2021, 14 (7), 686. https://doi.org/10.3390/ph14070686
Reddy, M.; Gill, S. S.; Kalkar, S. R.; Wu, W.; Anderson, P. J.; Rochon, P. A. Oral drug therapy for multiple neglected tropical diseases: A systematic review. JAMA. 2007, 298 (16), 1911–1924. https://doi.org/10.1001/jama.298.16.1911
Saranya, M.; Ayyappan, S.; Nithya, R.; Sangeetha, R. K.; Gokila, A. Molecular structure, NBO and HOMO-LUMO analysis of quercetin on single layer graphene by density functional theory. Dig. J. Nanomater. Biostructures. 2018, 13 (1), 97–105.
Sparg, S. G.; van Staden, J.; Jäger, A. K. Pharmacological and phytochemical screening of two Hyacinthaceae species: Scilla natalensis and Ledebouria ovatifolia. J. Ethnopharmacol. 2002, 80 (1), 95–101. https://doi.org/10.1016/S0378-8741(02)00007-7
Ugbe, F. A.; Shallangwa, G. A.; Uzairu, A.; Abdulkadir, I. Theoretical modeling and design of some pyrazolopyrimidine derivatives as Wolbachia inhibitors, targeting lymphatic filariasis and onchocerciasis. In Silico Pharmacol. 2022, 10, 8. https://doi.org/10.1007/s40203-022-00123-3
Wang, X.; Dong, H.; Qin, Q. QSAR models on aminopyrazole substituted resorcylate compounds as Hsp90 inhibitors. J. Comput. Sci. Eng. 2020, 48, 1146–1156.
World Health Organization (WHO). Schistosomiasis. Fact Sheet No 115; WHO, 2020. http://www.who.int/mediacentre/factsheets/fs115/en/. (accessed 2020-Jan-20)
World Health Organization (WHO). Control of neglected tropical diseases; WHO, 2022. http://www.who.int/teams/control-of-neglected-tropical-diseases/overview. (accessed 2020-Jan-20)